If you're a growth investor on the lookout for long-term options, then you could do a lot worse than these ASX growth shares listed below.
Here's why analysts are bullish on them and why they could be top long-term picks:
Breville Group Ltd (ASX: BRG)
The first ASX growth share that is rated as a buy is Breville.
It is of course the appliance manufacturer behind the eponymous Breville brand. However, its business doesn't stop there. Far from it! Breville also owns popular brands including Baratza, Kambrook, and Sage.
Goldman Sachs is a big fan of the company and believes it is well-placed to deliver strong earnings growth through to at least FY 2025. This is thanks partly to its exposure to the at-home coffee market. The broker commented:
We remain supportive of BRG's characteristics as a high quality name in a secular growth category and believe they will be able to demonstrate revenue and EBIT CAGR of 7.6% and 11.1% over FY22-25.
Goldman has a buy rating and $22.70 price target on the company's shares.
Corporate Travel Management Ltd (ASX: CTD)
Another ASX growth share that could be a buy is Corporate Travel Management.
Morgans is a big fan of the corporate travel booker and believes it is exceptionally well-placed for growth. This is thanks to acquisitions made during the pandemic, its significant cost reductions, and its market-leading technology.
In fact, the broker has named the company a key pick in the sector right now. It explains:
Taking a longer term view, CTD remains as a key pick for the travel sector. We see substantial upside in its share price as the company recovers from the COVID affected travel downturn. In fact, CTD should be a materially larger business post COVID given it has made two highly accretive acquisitions during the downturn. The company has also won a lot of new business, implemented structural cost out opportunities and continued to develop its market leading technology offering which means that it will require less staff in the future. CTD is well managed and has a strong balance sheet (no debt).
Morgans has an add rating and $24.00 price target on its shares.
